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ABSTRACT
Objective: To compare the prevalences of and risk
factors for asthma, wheeze, hay fever and eczema in
primary schoolchildren in Aberdeen in 2014.
Design: Cross-sectional survey.
Setting: Primary schools in Aberdeen, North-East
Scotland.
Participants: Children in Scottish school years
primary 1–7 were handed a questionnaire by their
class teacher to be completed by their parents and
returned to the researchers by post or online.
Main outcome measures: Lifetime history of
asthma, eczema and hay fever, and recent history of
wheeze.
Results: 41 schools agreed to participate (87%).
11 249 questionnaires were distributed and 3935
returned (35%). A parent-reported lifetime history of
asthma, eczema and hay fever was present in 14%,
30% and 24% of children, respectively. The odds of
lifetime asthma increased with age (OR 1.1 per year,
95% CI 1.1 to 1.2), male sex (OR 1.89, 95% CI 1.4 to
2.3), parental smoking (OR 1.7, 95% CI 1.2 to 2.3)
and eczema (OR 6.6, 95% CI 5.2 to 8.4). Prevalence of
recent wheeze was also reported to be 14% and was
positively associated with male sex, parental smoking
and eczema. In contrast, parental eczema was the only
identified predictor of childhood eczema risk.
Conclusions: The lifetime prevalence of asthma in
primary schoolchildren was 14% in this survey,
approximately half the prevalence of eczema. We report
diverging prevalences in relation to previous studies in
our locality, and different risk factors for asthma and
eczema. These findings suggest that asthma and
eczema are unlikely to have a common origin.
INTRODUCTION
Asthma is the most common chronic child-
hood medical condition worldwide1 and
places a signiﬁcant burden on family life,
society and healthcare systems.2 3 The preva-
lence of childhood asthma in Aberdeen, the
UK as a whole, and the wider western world
rose sharply during the second half of the
20th century. Since the turn of the century,
the global pattern has been far less certain.
A UK wide review has provided evidence of a
possible fall in childhood asthma preva-
lence.4 In Merseyside,5 a fall in childhood
asthma prevalence was witnessed between
1998 and 2006. Although a falling prevalence
of childhood asthma has also been detected
in Canada6 and Australia,7 it has been sug-
gested that, globally, rises remain more
common than falls.8 The International Study
of Asthma and Allergy in Children (ISAAC)
undertook three surveys of asthma preva-
lence in many countries between 1991 and
2003, and found evidence of asthma preva-
lence in 13–14 year olds still rising in some
countries (eg, Central America, Spain,
Portugal and Eastern Europe), of having
reached a plateau in some countries
(eg, New Zealand, Brazil and Uruguay) and
declining in some others (eg, the UK).9 As a
result of this widespread geographical vari-
ation in paediatric asthma prevalence,
repeated surveys in the same locations, which
give an insight into the burden of asthma
allow for the planning and delivery of
healthcare.
Strengths and limitations of this study
▪ The Aberdeen Schools Asthma Survey (ASAS) is
one of the longest-running paediatric epidemi-
ology studies in the world.
▪ It uses common methodology over successive
cross-sectional surveys of a defined population.
▪ ASAS 2014 includes the entire primary school
age and expands the geographical area to the
modern Aberdeen city boundaries, while main-
taining a subgroup using the old criteria for
comparison with previous ASAS.
▪ The use of imputation also enabled up to an
additional 349 children to be included in preva-
lence figures, increasing robustness.
▪ A limitation is the 35% response rate which may
limit the representativeness of the findings.
Barnish MS, et al. BMJ Open 2015;5:e008446. doi:10.1136/bmjopen-2015-008446 1
Open Access Research
group.bmj.com on February 2, 2018 - Published by http://bmjopen.bmj.com/Downloaded from 
The Aberdeen Schools Asthma Survey (ASAS) was ﬁrst
carried out in 1964 and is the longest-running series of
surveys of its kind in the UK and among the
longest-running worldwide. In Aberdeen schoolchildren
aged 9–12, the lifetime prevalence of asthma rose from
4% in 1964 to 28% in 2004, but fell to 22% in 2009. In
contrast with the fall in asthma (and wheeze) between
2004 and 2009, the prevalence of eczema and hay fever
remained relatively unchanged.10–12
The divergence in asthma and eczema prevalences
seen in Aberdeen 2004–2009, and elsewhere,13 lead us
to speculate that there may be different causal pathways
for asthma and eczema. Here we test the hypotheses
that (1) prevalences of asthma and eczema will continue
to diverge beyond 2009 in Aberdeen children and that
(2) different risk factors will be associated with asthma
and eczema. To test these hypotheses, and speciﬁcally to
increase the age range and socioeconomic diversity of
the study population, we modiﬁed the inclusion criteria
used in previous ASAS from children aged 9–12 attend-
ing schools within the 1964 Aberdeen City boundaries
to all primary school children (ie, aged 5–12) attending
schools within the 2014 Aberdeen City limits.
METHODS
Study design and setting
A cross-sectional survey design was used. All state-run
primary schools under the jurisdiction of Aberdeen City
Council in North-East Scotland were invited to participate.
Participants
All children in primary classes in participating schools
were eligible for the study. Class teachers in participating
schools distributed questionnaires to all children in the
primary classes of the school (Scottish school years
primary 1–7, approximate ages 5–12 years) in May 2014.
All previous ASAS were also carried out in May and this
consistency excludes the potential for seasonal variation
in asthma symptoms to inﬂuence parental recall and
reporting of symptoms. The study size was determined
by the number of children attending schools in
Aberdeen city, school participation rate and parental
response rate. Since this was a population epidemiology
study, it was not appropriate to predetermine a sample
size. Children gave the questionnaire to their parents,
who completed it at home and posted it directly to the
researchers. An electronic web-based response option
was offered as an alternative to the paper question-
naire. Although it was not possible to contact non-
responders directly due to the Data Protection Act
(1998; DPA), press releases were made and posters put
up at schools with historically low response rates in an
attempt to encourage parents to complete the question-
naire and thus, reduce response bias. The denominator
in calculating response rates was taken to be the school
roll ﬁgures provided by the school ofﬁce to the
researchers shortly prior to the delivery of question-
naires to the school.
Measures
The questionnaire validated in previous ASAS years was
distributed with a letter explaining its purpose. The key
questions included those asked since the 1964 survey:
‘Has your child wheezed or had a whistle in the chest in
the past three years?’, ‘Has your child ever had asthma?’,
‘Has your child ever had eczema?’ and ‘Has your child
ever had hay fever?’ Questions used in the wheeze
module of the ISAAC study9 have been included in 2004
and 2009 surveys and were also included in 2014, includ-
ing: ‘Has your child wheezed in the past 12 months?’.
Questions from the Changes in Childhood Exposure to
Environmental Tobacco Smoke (CHETS) study14 were
also included this year to explore in more detail chil-
dren’s risk of secondhand smoke exposure. Full details
of the questionnaire are presented in the online supple-
ment. A 10% random re-entry check, conducted on the
data for quality control purposes, was completed success-
fully. Socioeconomic classiﬁcation at the postcode level
was obtained for each participating child using the 2012
Scottish Index of Multiple Deprivation (SIMD),15 which
is the ofﬁcial index of socioeconomic status used by the
Scottish Government and covers seven domains: income,
employment, health, education, geographic access,
housing and crime. The SIMD quintile measure was
used to code socioeconomic status from 1 (least
deprived) to 5 (most deprived).
Data analysis
Imputation of missing values
As previously,12 imputation of asthma, eczema and hay
fever was conducted for responses where only the
wheeze question was answered.
Descriptive prevalence statistics
Mean prevalence with SD and 95% CIs were calculated
for the lifetime prevalence of asthma, eczema, hay fever,
wheeze in the past 12 months and wheeze in the past
3 years. These ﬁgures were for all children and separ-
ately for boys and girls. A subgroup of children aged
9–12 at school within the 1964 Aberdeen city boundaries
was created to allow for direct comparisons with previous
ASAS studies.
Predictors of childhood wheeze, asthma, eczema and hay fever
Five logistic regression models were constructed with
observed prevalence of wheeze in the past 12 months
and past 3 years, and lifetime asthma, eczema and hay
fever as dependent variables. Age, sex, SIMD and
number of parental smokers were included as independ-
ent variables. Parental prevalence for the corresponding
child outcome measure was included in models of
asthma, eczema and hay fever. Eczema was also included
as an index of atopy in the models where asthma,
wheeze and hay fever were the outcome. Standard statis-
tical software was used (SPSS V.22.0.0.1 IBM, Armonk,
New York, USA) and a p value of<0.05 was assumed to
be signiﬁcant.
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RESULTS
Study participants
Forty-one (87%) of 47 schools invited to take part
agreed to participate. According to projected school roll
ﬁgures for 2014,16 this denied access to 1585 children.
There was, however, no discernible socioeconomic
pattern with regard to school participation. There were
11 249 children in participating schools with 3935 ques-
tionnaires returned (35%). School-level response rates
ranged from 17% to 60%. Higher SIMD was associated
with signiﬁcantly higher response rates (r41=0.609,
p<0.001). Figure 1 shows the detailed recruitment
pathway for ASAS 2014.
Prevalences of asthma, eczema, hay fever and wheeze
The prevalence estimates for asthma, eczema and hay
fever, 12 month wheeze and 3 year wheeze were 14%,
30%, 24%, 14% and 18%, respectively, for the entire
data set (table 1). Excluding completely blank question-
naires, the missing data rates were 1% for age, gender
and 12 month wheeze, 3% for SIMD and 3 year wheeze,
9% for lifetime eczema prevalence and 10% for lifetime
asthma and hay fever prevalence. Among the subgroup
for comparison with previous ASAS surveys (ie, those
aged 9–12 and within the 1964 city boundaries), the
prevalence of asthma, eczema, hay fever, 12 month and
3 year wheeze were 19%, 29%, 30%, 14% and 18%
(table 2), respectively. Time trends for asthma, eczema,
hay fever and wheeze are shown in ﬁgure 2. Raw com-
parable data for 2014 are provided in table 2 and those
for previous years can be found in our previous
reports.10–12
Factors associated with asthma and other outcomes
Wheeze in the past 12 months and 3 years were signiﬁ-
cantly associated with male sex, parental smoking and
childhood eczema, but not with age or SIMD. Lifetime
prevalence of asthma was positively associated with age,
male sex, parental smoking, childhood eczema and par-
ental asthma, but not with SIMD. Lifetime prevalence of
eczema was signiﬁcantly associated with parental
eczema, but not with age, sex, SIMD or parental
smoking. Lifetime prevalence of hay fever was associated
with increased age, male sex, childhood eczema and par-
ental hay fever, but not with SIMD or parental smoking
(table 3).
DISCUSSION
Childhood asthma and atopy (as evidenced here by
eczema) are common chronic conditions which lead to
morbidity and poor quality of life for both child and
parent and therefore, merit close surveillance to allow
planning of healthcare delivery. ASAS 2014 provides an
up-to-date assessment of asthma and eczema prevalence,
and previous survey results have been consistent with
prevalences in the UK. The ﬁrst main ﬁnding of this
study is that asthma and eczema both remain common
in today’s childhood population. Asthma, but not
eczema, prevalence has fallen since our 1999 and 2004
surveys, but is still approximately twice the prevalence
reported in 1989. The second main ﬁnding is the diver-
gent trends in asthma and eczema prevalence which,
coupled with the associations between age, parental
smoking and sex with asthma but not with eczema,
suggest that there may be different underlying causal
pathways for asthma and atopy or non-respiratory aller-
gic conditions. The fall in asthma prevalence and its
association with parental smoking is pertinent in the
context of the Smoking, Health and Social Care
(Scotland) Act (2005) which prohibited smoking in
enclosed public spaces from March 2006. There is evi-
dence that this Act has reduced childhood hospital
admissions for asthma.17 Ours is the ﬁrst survey of child-
hood asthma prevalence in a Western European popula-
tion since our previous publication in 201112 and gives a
novel insight into the burden of childhood asthma; we
are conﬁdent that the prevalence of childhood asthma
is falling and the trend since 2004 suggests that a further
fall might be anticipated. Falling asthma prevalence
since the year 2000 has previously been noted in
Aberdeen12 and Merseyside5 in the UK, as well as in
Ontario, Canada7 and Belmont, New South Wales,
Australia.8 Therefore, the prevalence results reported
here are in keeping with observed trends in the UK and
certain other Western countries and provide evidence
for a continuation of these trends in these localities to
2014. However, the generalisability of asthma epidemio-
logical studies is limited to some extent by widespread
geographical variation in prevalence values and trends
as revealed by ISAAC.9
The relationship between asthma and atopic condi-
tions, such as eczema and hay fever, is complex and our
study highlights some of these inconsistencies. For
Figure 1 Consort-style figure summarising the number of
participants in the 2014 Aberdeen Schools Asthma Survey.
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Table 1 Demographics and prevalence of wheeze, asthma, eczema and hay fever among primary schoolchildren aged 5–12 in Aberdeen city in 2014
Boys Girls Total
Raw Imputed Raw Imputed Raw Imputed
N (%)a 1896 (48%) 1903 (48%) 3935 (100%)
Ageb 9.1 (9.0 to 9.2) 8.9 (8.8 to 9.0) 9.0 (9.0 to 9.1)
SIMDc 5 (2) 4 (2) 4 (2)
Parental smokers
Neither 1531 (81%) 1518 (80%) 3183 (81%)
One 239 (13%) 260 (14%) 501 (13%)
Both 126 (7%) 125 (7%) 251 (6%)
Parental asthma
Neither 1180 (69%) 1189 (69%) 2374 (69%)
One 473 (28%) 465 (27%) 939 (27%)
Both 60 (4%) 65 (4%) 125 (4%)
Parental eczema
Neither 1178 (72%) 1200 (73%) 2383 (73%)
One 405 (25%) 405 (25%) 811 (25%)
Both 47 (3%) 41 (3%) 88 (3%)
Parental hay fever
Neither 804 (47%) 818 (48%) 1626 (47%)
One 699 (41%) 666 (39%) 1367 (40%)
Both 219 (13%) 225 (13%) 444 (13%)
Child asthmad (Ne=3426) 17.3 (15.5 to 19.1) 17.0 (15.2 to 18.8) 11.1 (9.6 to 12.6) 11.2 (9.7 to 12.7) 14.2f (13.0 to 15.4) 14.1 (12.9 to 15.2)
Child eczemad (Ne=3462) 31.2 (29.0 to 33.4) 31.4 (29.2 to 33.6) 29.1 (27.0 to 31.2) 29.0 (26.9 to 31.2) 30.2 (28.6 to 31.7) 30.2 (28.7 to 31.7)
Child hay feverd (Ne=3425) 26.6 (24.5 to 28.7) 26.78 (24.6 to 28.8) 21.6 (19.6 to 23.5) 21.9 (19.9 to 23.8) 24.1g (22.7 to 25.5) 24.3 (22.8 to 25.7)
Child wheeze 3 years (N=3800) 21.5 (19.7 to 23.4) 15.4 (13.8 to 17.0) 18.4f (17.29 to 19.7)
Child wheeze 12 monthsd (N=3772) 16.2 (14.6 to 17.9) 11.8 (10.4 to 13.3) 14.0f (12.9 to 15.1)
a, There were 136 children (4%) of undeclared gender, b, mean (95% CIs), c, median quintile (IQR), d, % (95% CIs), e, for raw data, f, significant gender difference at p<0.001 (assessed on
raw data), g, significant gender difference at p<0.01.
SIMD, Scottish Index of Multiple Deprivation.
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Table 2 Demographics and prevalence of wheeze, asthma, eczema and hay fever among primary schoolchildren aged 9–12 in the 1964 city of Aberdeen in 2014.
Boys Girls Total
Raw Imputed Raw Imputed Raw Imputed
N (%) 402 (50%) 406 (50%) 808 (100%)
Agea 11.29 (11.18 to 11.3) 11.11 (11.0 to 11.2) 11.2 (11.1 to 11.2)
SIMDb 3 (3) 3 (3) 3 (3)
Parental smokers
Neither 306 (76%) 298 (73%) 606 (75%)
One 58 (14%) 77 (19%) 135 (17%)
Both 38 (10%) 31 (8%) 69 (9%)
Parental asthma
Neither 248 (70%) 253 (70%) 501 (70%)
One 98 (28%) 88 (24%) 186 (26%)
Both 9 (3%) 19 (5%) 28 (4%)
Parental eczema
Neither 233 (71%) 258 (75%) 491 (73%)
One 89 (27%) 75 (22%) 164 (24%)
Both 7 (2%) 12 (4%) 19 (3%)
Parental hay fever
Neither 178 (51%) 175 (48%) 353 (49%)
One 130 (37%) 147 (41%) 277 (39%)
Both 44 (13%) 41 (11%) 85 (12%)
Child asthmac (Nd=720) 23.6 (19.2 to 27.9) 23.2 (18.9 to 27.6) 13.7 (10.1 to 17.2) 14.0 (10.4 to 17.6) 18.6e (15.8 to 21.5) 18.6 (15.8 to 21.5)
Child eczemac (Nd=708) 28.6 (23.8 to 33.3) 29.0 (24.3 to 33.8) 29.15 (24.3 to 33.8) 29.2 (24.5 to 33.9) 28.8 (25.5 to 32.2) 29.1 (25.9 to 32.5)
Child hay feverc (Nd=724) 29.9 (25.3 to 34.7) 30.3 (25.6 to 35.1) 29.8 (25.0 to 34.4) 30.1 (25.4 to 34.8) 29.8e (26.5 to 33.2) 30.2 (26.9 to 33.6)
Wheeze 3 yrs (N=805) 23.9 (19.8 to 28.1) 12.6 (9.4 to 15.9) 18.3e (15.6 to 20.9)
Wheeze 12 mthsc (N=800) 17.8 (14.0 to 21.5) 10.0 (7.1 to 12.9) 13.9e (11.58 to 16.3)
a, mean (95% CIs), b, median quintile (IQR), c, % (95%CI), d, for raw data, e, significant gender difference at p<0.001 (assessed on raw data).
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example, the parallel rise in asthma and eczema preva-
lence seen in ASAS between 1964 and 2004, and the
sixfold increased risk for a child with asthma also having
eczema suggest that there might be a common origin
for both conditions. Conversely, the divergent trends in
prevalence since 2004 and the associations with gender,
age and parental smoking for asthma but not eczema
are inconsistent with a common origin hypothesis. Hay
fever can be considered an allergic condition of the
upper airways and our observations show common risk
factors for hay fever and asthma, but the same preva-
lence for eczema. This might be explained by hay fever
being a hybrid condition that shares an underlying asth-
matic airway abnormality in the upper respiratory tract
along with systemic atopy. Atopy is an immunological
condition, and eczema18 and skin prick reactivity19 in
infancy are associated with increased risk for later
asthma, but there is increasing recognition that the
airway epithelial cell, and not the humoral immune
system, is important to the development of asthma.20
Other reasons for falling prevalence in asthma but not
eczema prevalence include changes in diagnostic
practice for asthma, but not eczema, and reduced expos-
ure to secondhand smoke (shown here to be related to
asthma but not eczema prevalence).
A major strength of ASAS is the common method-
ology used over successive instances of the
longest-running series of paediatric asthma epidemi-
ology studies in the UK and one of the longest-running
surveys worldwide. A further strength of ASAS 2014 is
the inclusion of a wider age range and updating of the
geographical area to the modern city boundaries, which
include many suburban developments built following
the expansion of the oil industry in Aberdeen in the
1970s and 1980s. This increases its generalisability to the
modern population; however, a subgroup was retained
using the previous criteria for comparability with earlier
studies. Moreover, the sample characteristics of the com-
parable subgroup in ASAS 2014 are closely matched to
those of previous ASAS, suggesting that reduced
response rate is unlikely to have fundamentally changed
our sample characteristics. The use of imputation also
enabled up to an additional 349 children to be included
in prevalence ﬁgures increasing the robustness. A
Figure 2 Time trends for prevalence of wheeze, asthma, eczema and hay fever among primary schoolchildren aged 9–12 in
the 1964 city of Aberdeen 1964–2014. Dots on the line represent mean prevalence and bars represent 95% CIs.
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limitation is the 35% response rate which may limit the
representativeness of the ﬁndings. Although there was a
signiﬁcant association between SIMD and school-level
response rate, SIMD was not associated with the study
outcome measures. It is possible that parents of children
with asthma were more likely to participate, but this sam-
pling bias would have reduced not exaggerated our
observed fall in asthma prevalence and would not
threaten the validity of our ﬁnding of divergent preva-
lences for asthma and eczema. Although this approach
is widely used and validated in epidemiology, this ASAS,
as per all previous ASAS since 1989, relied on parents’
report and it is possible that this could have introduced
diagnostic bias.
In light of the falling response rates in surveys, such
as ours in the UK21 and elsewhere,22 it is important to
consider whether traditional epidemiological methods
are the best approaches to take in future. Although
lower than ASAS 2004 (57%)10 and 2009 (54%),12 our
response rate is higher than the 2006 childhood
asthma epidemiology study in Merseyside (30%)5 and
an epidemiological study in a different disease area run
by a separate team in Aberdeen (33%).23 Falling
response rates are likely to result from a combination
of several factors, including DPA which was instituted in
2000,16 survey fatigue17 and an increase in unsolicited
mailing,17 that we and other researchers are unable to
address. The response rate in ASAS fell from 85% in
ASAS 1999 prior to the enactment of DPA to 57% in
ASAS 2004—the ﬁrst ASAS in the DPA era. Therefore,
it might be better for future UK childhood asthma epi-
demiological studies to consider using alternative
approaches such as anonymised general practitioner
prescribing or hospital admissions data to provide a
whole population perspective, although these
approaches preclude asking targeted questions and rely
on information already held on clinical databases. In
addition, these approaches do not rely on self-reported
or parent-reported measures.
In summary, we report diverging prevalence ﬁgures
and different predictors for asthma and eczema in
primary schoolchildren in Aberdeen, Scotland. These
ﬁndings are not consistent with the hypothesis that
paediatric asthma and eczema have a common origin,
suggesting that the conditions are likely to have different
underlying mechanisms of action.
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